Read + Share
Armstrong AJ, Dietz H, Balli D, Geese WJ, et al. LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An
Analysis of the Phase III CheckMate-026 Randomized Trial. Clin Cancer Res 2025;31:5198-5210.
PMID: 41065506
|
 |
|
Armstrong AJ, Dietz H, Balli D, Geese WJ, et al. LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An
Analysis of the Phase III CheckMate-026 Randomized Trial. Clin Cancer Res 2025;31:5198-5210.
PMID: 41065506
|
|
|
|